Altamira Therapeutics Ltd...
(CYTO)
undefined
undefined%
At close: undefined
0.49
11.61%
After-hours Dec 13, 2024, 07:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -3.87M | -26.53M | -17.39M | -8.20M | -6.63M | -11.50M | -24.41M | -30.66M | -29.71M | -18.19M | -15.00M | -4.60M |
| Depreciation & Amortization | 119.30K | 118.89K | 76.36K | 20.04K | 30.82K | 72.71K | 122.78K | 97.60K | 92.78K | 73.98K | 37.52K | 9.24K |
| Stock-Based Compensation | - | 342.80K | 1.21M | 368.79K | 226.60K | 27.73K | 354.85K | 290.78K | 311.67K | 270.75K | 110.20K | 56.01K |
| Other Working Capital | -3.92M | 2.73M | 1.35M | 46.09K | -1.21M | -3.09M | 168.98K | -360.55K | 3.69M | 350.42K | 229.91K | - |
| Other Non-Cash Items | -3.42M | 13.83M | 1.90M | 2.69M | -601.08K | 474.70K | 142.04K | 679.38K | -36.39K | -2.50K | 36.20K | -5.83K |
| Deferred Income Tax | -99.85K | -10.33K | 21.62K | -21.28K | -193.84K | 162.18K | -17.77K | -131.06K | -1.06M | -4.09M | 305.75K | 30.46K |
| Change in Working Capital | -4.24M | 3.56M | 511.11K | 300.52K | -1.22M | -2.47M | -468.19K | 271.93K | 1.67M | 2.61M | 471.22K | 14.05K |
| Operating Cash Flow | -11.51M | -8.68M | -13.67M | -4.84M | -8.39M | -13.23M | -24.28M | -29.45M | -28.73M | -19.32M | -14.04M | -4.50M |
| Capital Expenditures | - | -2.14M | -3.33M | -2.32M | -3.02M | -1.89M | -152.97K | -244.32K | -79.92K | -1.24M | -108.94K | -131.75K |
| Acquisitions | 1.43M | - | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | -179.10K | - | - | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | 10.04K | - | - | - | - | - | - | - | - | - | - | 72.85K |
| Other Investing Acitivies | 505.00 | 969.00 | -179.10K | 258.00 | 17.88K | 68.16K | 53.57K | 67.55K | 36.56K | 52.13K | 74.04K | 5.83K |
| Investing Cash Flow | 1.44M | -2.14M | -3.51M | -2.31M | -3.00M | -1.82M | -99.40K | -176.77K | -43.36K | -1.19M | -34.90K | -53.08K |
| Debt Repayment | 1.05M | 5.92M | -68.70K | 1.52M | -1.46M | -9.27M | -2.09M | 11.99M | - | - | 13.77M | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 9.57M | 3.91M | 6.68M | 15.44M | -952.36K | -2.44M | -2.73M | -548.03K | -152.11K | -428.69K | -9.91K | - |
| Financial Cash Flow | 10.62M | 9.83M | 6.61M | 16.96M | 7.38M | 5.73M | 8.22M | 11.44M | 20.92M | 49.61M | 37.88M | 3.86M |
| Net Cash Flow | 602.01K | -968.80K | -10.27M | 9.87M | -4.01M | -9.58M | -17.47M | -17.80M | -6.70M | 33.07M | 23.80M | -688.91K |
| Free Cash Flow | -11.51M | -10.83M | -17.00M | -7.16M | -11.41M | -15.12M | -24.43M | -29.70M | -28.81M | -20.55M | -14.15M | -4.63M |